JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(3):141-145

Chitosan in topical preparations

D. Matušová, E. Truplová
Fakulta zdravotníckych špecializačných štúdií SZU v Bratislave, Katedra farmaceutickej technológie

Within the framework of experimental work at the Department of Pharmaceutical Technology of Slovak Medical University, "insect" chitin obtained from the buff-tailed bumblebee (Bombus terrestris) was processed to produce dosage forms and compared with commercially available chitin, or chitosan, obtained from shrimps (Pandalus borealus). The paper aimed to find whether insect chitin, or chitosan, possessed similar technological properties as commercially available and for topical preparations used products. Samples were prepared containing chitin, or chitosan, of different origin, 0.25 and 0.5 % in a gel base. In some gels the gel base was acidified with citric acid (in an amount of 0.75 %) or lactic acid (1 %) to improve the mechanical properties of foils. All samples were well applicable and after drying a relatively resistant transparent layer was formed on the skin. All samples could be made to produce elastic foils, which after moistening clung well to the skin. Both chitin and chitosan obtained from the bodies of buff-tailed bumblebees differed from reference materials obtained from shrimps by the degree of deacetylation, possessed different technological properties, e.g., finer fibres, were more fragile, and when wet, they could be disintegrated better, which is obvious also from the results of microscopic evaluation. Chitosan prepared from chitin SAV (insect) possessed substantially finer particles in the dosage form. The evaluation of the flow properties of the prepared samples revealed that except Sample I (gel base alone) they are timedependent tixotropic systems. Whereas chitin gels did not show any antimicrobial effect (which is apparently connected with bad solubility of chitin), gels with chitosan showed this activity. A more marked effect was observed in the strains of Staphylococcus aureus and Pseudomonas aeruginosa, and in Escherichia coli it was weaker. The paper reports the first tentative results of comparisons of chitin- and chitosan-containing gels obtained from insects and those obtained from shrimps, showing that the prepared samples were of comparable quality.

Keywords: chitin; chitosan; insects; shrimp; topical dosage form

Received: April 13, 2007; Accepted: May 11, 2007; Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matušová D, Truplová E. Chitosan in topical preparations. Čes. slov. farm. 2007;56(3):141-145.
Download citation

References

  1. Kopecký, F., Kopecká, B., Semjanová, O.: Čes. slov. Farm., 2002; 51, 134-139.
  2. Onar, N., Sariisik, M.: Using and properties biofibers based on chitin and chitosan on medical applications. conference_proceedings/fulltext/Turkey_05.pdf
  3. Majtán, J., Bíliková, K., Markovič, O. et al.: Isolation and characterization of chitin from bumblebee (Bombus terrestris), Int. J. Biomac., 2006 (v tlači). Go to original source... Go to PubMed...
  4. Kato, Y., Onishi, H., Machida, Y.: Curr. Pharm. Biotechnology, 2003; 4, 303-309. Go to original source... Go to PubMed...
  5. Jumaaa, M., Furkertb, F. H., Müller, B. W.: Eur.J.Pharm.Biopharm., 2002; 53, 115-123. Go to original source... Go to PubMed...
  6. Shinn, A. H., Smith, T. J.: BioPharm International, 2003; 11, www.biopharm-mag.com/biopharm
  7. Erbacher, P.. et al.: Pharm. Res., 1998; 15, 1332-1339. Go to original source... Go to PubMed...
  8. Strand, S. P., Danielsen, S., Christensen, B. E., Varum, K. M.: Biomacromolecules, 2005; 6, 3357-3366. Go to original source... Go to PubMed...
  9. Khan, T. A., Peh, K. K., Ch'ng, H. S.: J. Pharm. Pharm. Sci. (), 2000; 3, 303-311.
  10. Cho, Y. W., Cho, Y.N., Chung, S.H. et al.: Biomaterials, 1999; 22, 2139-2145. Go to original source... Go to PubMed...
  11. Marreco, P. R., da Luz Moreira, P., Genari, S. C., Moraes, A. M.: J. Biomed. Mater. Res. - B, 2004; 71, 268-277. Go to original source... Go to PubMed...
  12. Risbud, M., Hardikar, A., Bhonde, R.: J. Bioscience, 2000; 25, 25-31. Go to original source... Go to PubMed...
  13. Paul, W., Sharma, CH. P.: Trends Biomater. Artif. Organs, 2004; 18, 18-23.
  14. Ofori-Kwakye, K., Fell, J. T.: Int. J. Pharm., 2003; 250, 251-257. Go to original source... Go to PubMed...
  15. Ismarul, I. N., Ishak, Y., Ismail, Z. et al.: Med. J. Malaysia, 2004; 59, 57-58.
  16. Fisher, S.: Natural polymers reinforced by inorganic nano-particles. 2005, TNO Industrial Technology, Eindhoven, The Netherlands.
  17. Záthurecký, L., Hlavatý, P., Malovíková, A.: Štandardný gélový základ na prípravu magistraliter prípravkov pre dermatológiu. Rezortná tematická úloha MzaSV SSR č.1/1998.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.